Peter C. Dau

2.5k total citations
55 papers, 1.7k citations indexed

About

Peter C. Dau is a scholar working on Neurology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Peter C. Dau has authored 55 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 16 papers in Immunology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Peter C. Dau's work include Peripheral Neuropathies and Disorders (14 papers), Myasthenia Gravis and Thymoma (12 papers) and Multiple Sclerosis Research Studies (9 papers). Peter C. Dau is often cited by papers focused on Peripheral Neuropathies and Disorders (14 papers), Myasthenia Gravis and Thymoma (12 papers) and Multiple Sclerosis Research Studies (9 papers). Peter C. Dau collaborates with scholars based in United States and Germany. Peter C. Dau's co-authors include Eric H. Denys, Lynn E. S̄pitler, Christine K. Cassel, Edward E. Shev, Jon Lindstrom, Jack H. Petajan, M. Bashar Kahaleh, Richard W. Sagebiel, J Lindström and James L. Bennington and has published in prestigious journals such as New England Journal of Medicine, Neurology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Peter C. Dau

55 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter C. Dau United States 24 783 464 358 273 219 55 1.7k
Piero Marson Italy 24 188 0.2× 351 0.8× 170 0.5× 260 1.0× 380 1.7× 101 1.4k
Shifra Ash Israel 22 327 0.4× 176 0.4× 133 0.4× 176 0.6× 96 0.4× 86 1.6k
Gösta Berlin Sweden 22 142 0.2× 328 0.7× 145 0.4× 362 1.3× 88 0.4× 76 1.7k
Henry E. Wilson United States 21 345 0.4× 188 0.4× 1.1k 3.0× 266 1.0× 47 0.2× 45 2.2k
Joseph M. Kiely United States 18 318 0.4× 84 0.2× 452 1.3× 296 1.1× 52 0.2× 39 1.3k
Naoe Goto Japan 22 128 0.2× 238 0.5× 470 1.3× 203 0.7× 85 0.4× 66 1.2k
Mauro Galeazzi Italy 20 156 0.2× 755 1.6× 269 0.8× 134 0.5× 1.5k 7.0× 51 2.1k
Neta Goldschmidt Israel 23 217 0.3× 148 0.3× 514 1.4× 93 0.3× 126 0.6× 97 1.4k
Minnie Abromowitch United States 33 497 0.6× 147 0.3× 838 2.3× 146 0.5× 56 0.3× 67 3.0k
Elena Baldissera Italy 23 241 0.3× 601 1.3× 101 0.3× 297 1.1× 656 3.0× 65 2.0k

Countries citing papers authored by Peter C. Dau

Since Specialization
Citations

This map shows the geographic impact of Peter C. Dau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Dau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Dau more than expected).

Fields of papers citing papers by Peter C. Dau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Dau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Dau. The network helps show where Peter C. Dau may publish in the future.

Co-authorship network of co-authors of Peter C. Dau

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Dau. A scholar is included among the top collaborators of Peter C. Dau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Dau. Peter C. Dau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Head, Trajen, Peter C. Dau, Stéphanie Duffort, et al.. (2017). An enhanced bioluminescence-based Annexin V probe for apoptosis detection in vitro and in vivo. Cell Death and Disease. 8(5). e2826–e2826. 32 indexed citations
2.
3.
Dau, Peter C.. (1996). The fundamental basis for therapeutic plasmapheresis in autoimmune diseases. Transfusion Science. 17(2). 235–244. 4 indexed citations
4.
Dau, Peter C.. (1995). Immunologic rebound. Journal of Clinical Apheresis. 10(4). 210–217. 27 indexed citations
5.
Dau, Peter C.. (1995). Increased antibody production in peripheral blood mononuclear cells after plasma exchange therapy in multiple sclerosis. Journal of Neuroimmunology. 62(2). 197–200. 22 indexed citations
6.
Dau, Peter C., et al.. (1995). Intrafamily fragment analysis of the T cell receptor β chain CDR3 region. Journal of Immunological Methods. 187(1). 139–150. 10 indexed citations
7.
Dau, Peter C.. (1994). Immunomodulation during treatment of polymyositis with plasmapheresis and immunosuppressive drugs. Journal of Clinical Apheresis. 9(1). 21–25. 10 indexed citations
8.
Dau, Peter C., et al.. (1994). Immune Modulation during Treatment of Systemic Sclerosis with Plasmapheresis and Immunosuppressive Drugs. Clinical Immunology and Immunopathology. 70(2). 159–165. 24 indexed citations
9.
Gordon, Bruce R., Sheryl F. Kelsey, David W. Bilheimer, et al.. (1992). Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The American Journal of Cardiology. 70(11). 1010–1016. 79 indexed citations
10.
Clark, William F., Peter C. Dau, Hans H. Euler, et al.. (1991). Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: Design of the LPSG trial. Journal of Clinical Apheresis. 6(1). 40–47. 39 indexed citations
11.
Dau, Peter C.. (1991). Plasmapheresis in acute multiple sclerosis: Rationale and results. Journal of Clinical Apheresis. 6(4). 200–204. 7 indexed citations
12.
Dau, Peter C.. (1990). Increased proliferation of blood mononuclear cells after plasmapheresis treatment of patients with demyelinating disease. Journal of Neuroimmunology. 30(1). 15–21. 25 indexed citations
13.
Weiner, Howard L., Peter C. Dau, B. Khatri, et al.. (1989). Double‐blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology. 39(9). 1143–1143. 111 indexed citations
14.
Dau, Peter C., et al.. (1988). Treatment of hypercholesterolemia by precipitation of lipoproteins with dextran sulfate. Journal of Clinical Apheresis. 4(2-3). 72–77. 2 indexed citations
15.
Dau, Peter C.. (1988). Remission of hyper‐lgE syndrome treated with plasmapheresis and cytotoxic immunosuppression. Journal of Clinical Apheresis. 4(1). 8–12. 6 indexed citations
16.
Klein, Harvey G., Peter C. Dau, Max Hamburger, et al.. (1986). Announcement. Journal of Clinical Apheresis. 3(1). i–vi, 1. 18 indexed citations
17.
Dau, Peter C.. (1983). Therapeutic Plasma Exchange: Dermatologic Applications. Dermatologic Clinics. 1(4). 571–589. 6 indexed citations
18.
Dau, Peter C., et al.. (1981). Skin Ultrastructural Changes in Hallervorden‐Spatz Syndrome. Neurology. 31(7). 923–923. 1 indexed citations
19.
Dau, Peter C. & James L. Bennington. (1981). Plasmapheresis in childhood dermatomyositis. The Journal of Pediatrics. 98(2). 237–240. 31 indexed citations
20.
Dau, Peter C.. (1970). Transformation of Lymphocytes From Patients With Multiple Sclerosis. Archives of Neurology. 23(1). 32–32. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026